Umamaheswari Ramachandran

Array ( [id] => 8464697 [patent_doc_number] => 20120269865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'NUTRITIONAL COMPOSITION FOR PROMOTING GUT MICROBIOTA BALANCE AND HEALTH' [patent_app_type] => utility [patent_app_number] => 13/502918 [patent_app_country] => US [patent_app_date] => 2010-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 21868 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5984656 [patent_doc_number] => 20110097348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'Protein Formulation' [patent_app_type] => utility [patent_app_number] => 12/913857 [patent_app_country] => US [patent_app_date] => 2010-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5315 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20110097348.pdf [firstpage_image] =>[orig_patent_app_number] => 12913857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10044361 [patent_doc_number] => 09084743 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-21 [patent_title] => 'Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/807991 [patent_app_country] => US [patent_app_date] => 2010-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57989 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 230 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12807991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7573071 [patent_doc_number] => 20110268727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'ANTI-INTERFERON-ALPHA ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/882980 [patent_app_country] => US [patent_app_date] => 2010-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 33336 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20110268727.pdf [firstpage_image] =>[orig_patent_app_number] => 12882980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6195508 [patent_doc_number] => 20110027262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'PLATFORM ANTIBODY COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/879916 [patent_app_country] => US [patent_app_date] => 2010-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 68867 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027262.pdf [firstpage_image] =>[orig_patent_app_number] => 12879916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6184021 [patent_doc_number] => 20110123566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'ENDOGENOUS ADJUVANT MOLECULES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/879471 [patent_app_country] => US [patent_app_date] => 2010-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19181 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20110123566.pdf [firstpage_image] =>[orig_patent_app_number] => 12879471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6096127 [patent_doc_number] => 20110003314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'Hapten, Immunogens and Derivatives of Ascomycin Useful for Preparation of Antibodies and Immunoassays' [patent_app_type] => utility [patent_app_number] => 12/876837 [patent_app_country] => US [patent_app_date] => 2010-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4846 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003314.pdf [firstpage_image] =>[orig_patent_app_number] => 12876837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8227387 [patent_doc_number] => 20120141585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'IMMUNOMODULATORY COMPOSITIONS COMPRISING A POLYMER MATRIX AND AN OIL PHASE' [patent_app_type] => utility [patent_app_number] => 13/390085 [patent_app_country] => US [patent_app_date] => 2010-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 37863 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13390085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9033810 [patent_doc_number] => 20130236448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-12 [patent_title] => 'CONCENTRATED POLYPEPTIDE FORMULATIONS WITH REDUCED VISCOSITY' [patent_app_type] => utility [patent_app_number] => 13/388962 [patent_app_country] => US [patent_app_date] => 2010-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 25493 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134433 [patent_doc_number] => 20110008335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'Methods and Compositions for Increasing the Efficiency of Therapeutic Antibodies Using NK Cell Potentiating Compounds' [patent_app_type] => utility [patent_app_number] => 12/847090 [patent_app_country] => US [patent_app_date] => 2010-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17418 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008335.pdf [firstpage_image] =>[orig_patent_app_number] => 12847090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8197012 [patent_doc_number] => 20120121580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'METHODS FOR PRODUCING HIGH CONCENTRATION LYOPHILIZED PHARMACEUTICAL FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 13/387268 [patent_app_country] => US [patent_app_date] => 2010-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 20518 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20120121580.pdf [firstpage_image] =>[orig_patent_app_number] => 13387268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5976082 [patent_doc_number] => 20110070290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT' [patent_app_type] => utility [patent_app_number] => 12/843398 [patent_app_country] => US [patent_app_date] => 2010-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 35941 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20110070290.pdf [firstpage_image] =>[orig_patent_app_number] => 12843398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5992621 [patent_doc_number] => 20110014274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT' [patent_app_type] => utility [patent_app_number] => 12/843395 [patent_app_country] => US [patent_app_date] => 2010-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 35941 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20110014274.pdf [firstpage_image] =>[orig_patent_app_number] => 12843395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8264760 [patent_doc_number] => 20120164189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'Lipidic Compositions for Induction of Immune Tolerance' [patent_app_type] => utility [patent_app_number] => 13/382684 [patent_app_country] => US [patent_app_date] => 2010-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 13576 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13382684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070687 [patent_doc_number] => 20110045537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'Human Anti-IFN-gamma Neutralizing Antibodies as Selective IFN-gamma Pathway Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/831087 [patent_app_country] => US [patent_app_date] => 2010-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 30605 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20110045537.pdf [firstpage_image] =>[orig_patent_app_number] => 12831087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6118597 [patent_doc_number] => 20110076270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'Therapeutic Binding Molecules' [patent_app_type] => utility [patent_app_number] => 12/827642 [patent_app_country] => US [patent_app_date] => 2010-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19511 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20110076270.pdf [firstpage_image] =>[orig_patent_app_number] => 12827642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9850408 [patent_doc_number] => 08952138 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-10 [patent_title] => 'Refolding proteins using a chemically controlled redox state' [patent_app_type] => utility [patent_app_number] => 12/820087 [patent_app_country] => US [patent_app_date] => 2010-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10001 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12820087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5952477 [patent_doc_number] => 20110033493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'VACCINE' [patent_app_type] => utility [patent_app_number] => 12/813982 [patent_app_country] => US [patent_app_date] => 2010-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14852 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033493.pdf [firstpage_image] =>[orig_patent_app_number] => 12813982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6434870 [patent_doc_number] => 20100278907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'Immunogenic Compositions Containing Ceramide and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/778523 [patent_app_country] => US [patent_app_date] => 2010-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14927 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0278/20100278907.pdf [firstpage_image] =>[orig_patent_app_number] => 12778523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6474651 [patent_doc_number] => 20100284921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'TARGETED NANOPARTICLES FOR INTRACELLULAR CANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 12/776503 [patent_app_country] => US [patent_app_date] => 2010-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 28209 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0284/20100284921.pdf [firstpage_image] =>[orig_patent_app_number] => 12776503 [rel_patent_id] =>[rel_patent_doc_number] =>)